Allergan struck a $200 million deal to snag Motus Therapeutics in an effort to shore up its gastrointestinal therapies.
- Top 10 Pipelines 9,266 views
- Celgene Snaps Up Merck & Co.’s Giant Complex in New Jersey 8,600 views
- Annual Report: Top 10 Pipelines 6,600 views
- Top 100 Biotechnology Companies Special Report: The Acquisition Game 3,100 views